Fulcrum Therapeutics Inc (FULC)
8.73
-0.29%
Fulcrum Therapeutics Inc (FULC) is currently trading at $8.73. This represents a loss of 0.29% from the previous session. With a market capitalization of $0.46B, FULC is a key component of the Health Care sector. Investors looking to trade FULC should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade FULC commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Fulcrum Therapeutics Inc (FULC) shows a bearish trend. Analysts are watching the 8.91 level closely.
Fundamentals
Mkt Cap0.46B
P/E Ratio0.0000
Volume10,288
60-Day Technical Chart
Advanced Charting
Need more indicators for FULC? Use the world's #1 platform.
Open FULC on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $9
| Metric |
FULC -0.29% |
NVTS +13.51% |
MARA +6.02% |
SOUN +3.19% |
|---|---|---|---|---|
| Price | $8.73 | $9.35 | $8.55 | $8.63 |
| Mkt Cap | $0.46B | $2.22B | $3.21B | $3.63B |
| - | View → | View → | View → |
Latest Headlines
FULCRUM THERAPEUTICS ($FULC) Releases Q4 2025 Earnings
Quiver Quantitative • Feb 24, 2026
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Stock Titan • Feb 24, 2026
What's Going On With Fulcrum Therapeutics Stock Tuesday?
Benzinga • Feb 24, 2026
BofA reiterates Fulcrum Therapeutics stock Underperform rating at $7
Investing.com • Feb 24, 2026
Fulcrum Therapeutics (FULC) Shares Experience Unexpected Decline
GuruFocus • Feb 24, 2026
● Gemini Agentic AI Analyst Insight for FULC
Market Education
- Fails to Deliver DeMystified May 31, 2024
- Large Cap at Lowest Price Apr 9, 2024
- Trump’s New Tariffs Could Push Up Kitchen Renovation Costs Sep 26, 2025
External Research